(Q42906629)

English

Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

scientific article published on August 19, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS) (English)

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

author name string

Ingar Holme

1

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Niklas Hammar

3

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Ingmar Jungner

4

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Göran Walldius

5

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Are H. Aastveit

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843515

13 July 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0021915010006908?httpAccept=text/xml

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

https://api.elsevier.com/content/article/PII:S0021915010006908?httpAccept=text/plain

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

213

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

299-305

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools

1

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

2

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community

3

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study

4

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Leukocyte count is associated with incidence of coronary events, but not with stroke: a prospective cohort study

5

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes

6

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

8

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

The carotid artery plaque size and echogenicity are related to different cardiovascular risk factors in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study

9

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein

10

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

11

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

12

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

13

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).

14

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS).

15

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Increasing Stroke Incidence in Sweden Between 1989 and 2000 Among Persons Aged 30 to 65 Years: Evidence From the Swedish Hospital Discharge Register

16

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden

17

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females

18

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Apolipoprotein B and A-I values in 147 576 Swedish males and females, standardized according to the World Health Organization–International Federation of Clinical Chemistry First International Reference Materials

19

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.

20

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

The estimation of synergy or antagonism

22

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

23

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men.

24

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease

25

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Independent relationship of serum uric acid levels with leukocytes and coronary atherosclerotic burden.

26

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

27

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts

28

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Accuracy of a heart failure diagnosis in administrative registers

30

1 reference

10.1016/J.ATHEROSCLEROSIS.2010.08.049

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.049

13 July 2024

Identifiers

10.1016/J.ATHEROSCLEROSIS.2010.08.049

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42906629&oldid=2203416082"